Unlikely to cause harm — often a labeling or packaging issue.
Discoloration: This product is being recalled due to a confirmed pharmacist report that tablets from this lot were a pink color instead of cream (peach).
| Brand name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Generic name | AMLODIPINE AND OLMESARTAN MEDOXOMIL |
| Active ingredient(s) | AMLODIPINE BESYLATE, OLMESARTAN MEDOXOMIL |
| Distributed by / for | Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 |
| NDC | 65862-855-30 |
| Full product label | Amlodipine and Olmesartan Medoxomil Tablets, 5 mg/40 mg, Rx only, 30-count bottle, Distributed by: Aurobindo Pharma USA, Inc. 279 Princeton-Hightstown Road East Windsor, NJ 0852 Made in India, NDC 65862-855-30 |
| Recalling firm | Aurobindo Pharma USA Inc. |
| Distribution | U.S.A. Nationwide |
| Quantity | 4464 bottles |
| Recall initiated | 2018-11-30 |
| Report date | 2018-12-12 |
| Recall completed | 2022-02-01 |
| Recall number | D-0289-2019 |
| Classification | Class III |
| FDA status | Terminated |
| Origin on file | East Windsor NJ United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗